XML 48 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Components of Income (Loss) from Continuing Operations Before Income Taxes
The following table shows the components of (loss) income from continuing operations before income taxes (in thousands):

 
For the year ended December 31,
 
2017
 
2016
 
2015
 
 
 
 
 
 
United States
$
(11,382
)
 
$
(16,848
)
 
$
9,620

(Loss) income from continuing operations before income taxes
$
(11,382
)
 
$
(16,848
)
 
$
9,620


Schedule of Components of Benefits from Income Taxes
The following table shows the components of the provision for income taxes from continuing operations (in thousands):

 
For the year ended December 31,
 
2017
 
2016
 
2015
Current:
 
 
 
 
 
U.S. federal
$

 
$
1

 
$
123

State
10

 
26

 
26

Total current
$
10

 
$
27

 
$
149

 
 
 
 
 
 
Deferred:
 
 
 
 
 
U.S. Federal
$
(125
)
 
$

 
$

State
$

 
$

 
$

Total deferred
$
(125
)
 
$

 
$

 
 
 
 
 
 
Provision for income taxes
$
(115
)
 
$
27

 
$
149

Schedule of Effective Income Tax Rate Reconciliation
The principal items accounting for the difference between income taxes computed at the U.S. statutory rate and the provision for income taxes from continuing operations reflected in our Consolidated Statements of Operations are as follows:
  
 
For the year ended December 31,
 
2017
 
2016
 
2015
 
 
 
 
 
 
U.S. statutory rate
34.0
 %
 
34.0
 %
 
34.0
 %
State taxes (net of federal tax benefit)
2.3

 
1.7

 
0.2

Valuation allowance
17.4

 
(27.5
)
 
(27.9
)
Deferred rate change due to changes in tax laws
(51.7
)
 

 

Other
(1.0
)
 
(8.4
)
 
(4.8
)
 
1.0
 %
 
(0.2
)%
 
1.5
 %
Schedule of Deferred Tax Assets
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets are as follows (in thousands):
 
 
At December 31,
 
2017
 
2016
 
2015
 
 
 
 
 
 
Allowance for doubtful accounts
$

 
$
18

 
$
18

Accrued expenses and other reserves
1,749

 
3,138

 
2,244

Tax credits, deferred R&D, and other
197

 
142

 
122

Net operating loss
8,610

 
9,239

 
5,384

Valuation allowance
(10,556
)
 
(12,537
)
 
(7,768
)
Net deferred tax assets
$

 
$

 
$